Pharma Marketing News Vol. 10, No. 7: 15 April 2011
Welcome to Volume 10, Issue #7 (15 APRIL 2011) of Pharma Marketing News.
Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose?
The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.
Antidepressants: Top Advertised & 3rd Most Commonly Used Rx Drug
According to a recent CDC Data Brief, antidepressants were the third most common prescription drug taken by Americans of all ages in 2005–2008 and the most frequently used by persons aged 18–44 years. From 1988–1994 through 2005–2008, the rate of antidepressant use in the United States among all ages increased nearly 400%. Perhaps not so coincidentally, antidepressants are among the TOP advertised Rx category in 2010, according to the recent AdAge analysis.
Pharma Marketing News Vol. 10, No. 4: 23 FEBRUARY 2011
Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.
A New Estimate of Drug Development Cost
Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'
The Changing Pharma eDetailing Landscape
A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.
Pharma Marketing News Vol. 10, No. 4: 23 FEBRUARY 2011
Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.
Pharma Marketing News Vol. 10, No. 5: 10 MARCH 2011
Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.
Physicians Favor Brands With a Compelling Adherence Program
This article summarizes the results of a survey of physicians designed to assess the value of various adherence solutions -- including HealthPrize -- and the potential of these solutions to influence physicians' prescribing behavior.
Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
Let's Look at Some Data PhRMA Doesn't Mention. PhRMA pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be 'up-to-date, useful and reliable.'
